Preprint
Article
Respiratory Symptoms Among Adolescens in Poland: A Study on Cigarette Smokers, E-Cigarette Users, and Dual Users
Altmetrics
Downloads
103
Views
38
Comments
0
A peer-reviewed article of this preprint also exists.
This version is not peer-reviewed
Submitted:
13 May 2024
Posted:
13 May 2024
You are already at the latest version
Alerts
Abstract
In recent years, the prevalence of tobacco and electronic cigarette (e-cigarette) use among adolescents has raised significant public health concerns worldwide. This study aims to investigate respiratory symptoms among Polish adolescents. We conducted an online survey among Polish school students from all provinces, collecting data over two months in Spring 2021. Students voluntarily complete the anonymous survey, answering questions about respiratory symptoms, smoking habits (both traditional and electronic cigarettes), and demographic information. Analysis focused on four subgroups: non-tobacco users, traditional cigarette smokers, e-cigarette users, and dual users, totaling 10,388 pupils aged 12-18 years, predominantly attending secondary technical and comprehensive schools. A total of 10388 pupils participated in the study, 55.6 % (5778) of whom were girls and 44.4 % (4610) boys. Adolescents, who admitted using both e-cigarettes and traditional cigarettes experienced more frequent episodes of cough during the day (39.70%) and at night (18.40%) compared to their peers in other groups. Chest discomfort, including pain and pressure, was also reported more often by adolescents, who used e-cigarettes and traditional cigarettes concurrently (27.60%) compared to their peers in other groups. Chest pressure was experienced less commonly by non-smoking adolescents (14.40%) than by smokers (18.90%). Higher severity of cough during the day and at night was observed in the group of adolescents using traditional cigarettes and e-cigarettes concurrently compared to the other groups. The adolescents in the dual user group experienced more severe dyspnoea and wheezing compared to the other groups included in the comparison. The results of this study confirm the correlation between the occurrence of respiratory symptoms in adolescents who smoke cigarettes, use e-cigarettes and in dual users. The respiratory symptoms occur most frequently and are the most severe in the group of adolescents who use e-cigarettes and traditional cigarettes
Keywords:
Subject: Medicine and Pharmacology - Pediatrics, Perinatology and Child Health
1. Introduction
In the recent years, we have observed a dynamic increase in popularity of e-cigarettes (electronic cigarettes) among adolescents. In the studies conducted in Poland in 2016, it was noted that 28% boys and 18.6% girls aged 13-15 years declared using e-cigarettes [1]. What is more, 24% adolescents declared using both traditional cigarettes and e-cigarettes concurrently [2]. E-cigarettes are the most commonly used tobacco product among adolescents in the US, and the observed increasing percentage of smokers is attributed to e-cigarettes [3]. Results from the 2019 and 2020 National Youth Tobacco Survey (NYTS), conducted by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) demonstrated that electronic cigarettes were the most frequently used tobacco product among high school students (19.6%; 3.02 million) and junior high school students (4.7%; 550 thousand) [4].
Thus, they have become a subject of intense scientific, medical and social debate. The use of e-cigarettes, especially by adolescents, is still controversial in the context of public health studies [5-6]. Scientists frequently indicate adverse effects of e-cigarettes use on the respiratory system in smokers, including adolescents and young adults. The studies involving adolescents demonstrated a correlation between e-cigarettes use and increased incidence of bronchitis. Moreover, it was confirmed that both current and past use of e-cigarettes increases the probability of occurrence of the symptoms of bronchitis: cough and wheezing [7-8]. Similarly, in The Yale Adolescent Survey Study demonstrated that e-cigarette use for six or more days within the previous 30 days increased the risk of occurrence of bronchitis [9]. In turn, researchers from California demonstrated that the risk of occurrence of bronchitis increases with higher frequency of e-cigarette use within the previous 30 days [10]. In a study performed in the years 2012-2013 in Hong Kong, it was found that electronic cigarette use increases the risk of occurrence of chronic cough and bronchial secretions requiring evacuation [11]. There are also reports confirming a correlation between the use of e-cigarettes and the occurrence of asthma and its exacerbations. The results of studies performed in Florida [12] and Hawaii [13] confirmed the correlation between e-cigarette use and asthma in a group of young people. A study conducted among school students in South Korea evaluated the correlation between the use of e-cigarettes and the diagnosis of asthma within the previous 12 months. A comparison between current e-cigarette users and people who have never used electronic cigarettes demonstrated that unadjusted odds ratio (OR) for asthma in the smokers was 2.36 (95% CI: 1.89-2.94). What is more, it was demonstrated that adolescents currently using e-cigarettes were at a higher risk of asthma exacerbation, represented by the number of days they were absent at school due to the symptoms od asthma compared to adolescents not using e-cigarettes [14].
The aim of this work was to evaluate the occurrence of respiratory symptoms and their severity in a group of adolescents using e-cigarettes and ones using both e-cigarettes and traditional cigarettes, so called dual users.
2. Materials and Methods
In this study, we have used a proprietary online survey to evaluate the occurrence of respiratory symptoms in Polish school students. The invitation to participate and link to the online survey were sent by email to the management of primary schools and secondary schools from all provinces of Poland. The participants provided their voluntary consent to participate in the study by clicking the external link, which directed them to the online survey on the Surveymonkey platform. The data were being collected for two months - Spring 2021. The survey was fully anonymous. The following inclusion criteria were adopted: school students aged 12-18 years, in 6th-8th grade of the primary school and 1st-4th grade of the secondary school who were willing to participate in the study.
The survey included questions concerning the occurrence of respiratory symptoms, as well as traditional and electronic cigarette smoking habits in adolescents. The survey also let us collect demographic data, such as gender, age, school type, population of their locality, level of their parents’ education and tobacco smoking status. The students were asked to choose and mark their answer regarding the incidence and severity of particular symptoms. The symptom severity was presented in the survey on a scale from 0 to 10, where 0 meant no symptoms and 10 meant symptoms interfering with their daily activities. Only current smokers were included in the analysis of the symptom occurrence and severity. This group consisted of adolescents who answered “yes” to the question: “Have you smoked traditional cigarettes within the last 30 days?” and/or “Have you used electronic cigarettes within the last 30 days?” Adolescents who gave a positive answer to both these questions were classified as “dual users”. The statistical analysis was performed among four subgroups of school students: not using tobacco products (subgroup 1) (n = 8234), smoking only traditional cigarettes (subgroup 2) (n = 608), using only e-cigarettes (subgroup 3) (n = 879) and using traditional cigarettes and e-cigarettes concurrently (subgroup 4) (n = 667).
A total of 10388 pupils participated in the study, 55.6 % (5778) of whom were girls and 44.4 % (4610) boys. The median age was 16.16 years (SD=1.70). Considering the respondents’ schools, most of them attended secondary technical schools (4233 respondents, 40.7%). A smaller group attended secondary comprehensive schools (3376 respondents, 32.5%). Accordingly, 1988 respondents attended primary schools (19.1%), while only 791 students attended vocational schools (7.6%).
3. Results
The percentage of occurrence of the respective symptoms reported by the surveyed adolescents was presented in Table 1. The results for all symptoms were statistically significant (p < 0.001) but the effect size was low. In the latter stage of the study a post-hoc analysis of the results was performed using χ2 test with Bonferroni correction for multiple comparisons.
Adolescents, who admitted using both e-cigarettes and traditional cigarettes experienced more frequent episodes of cough during the day (39.70%) and at night (18.40%) compared to their peers in other groups. Additionally, these symptoms were reported by more adolescents smoking traditional cigarettes than non-smokers and e-cigarette users, however, they occurred equally frequently in non-smokers and e-cigarette users.
In the dual user group, dyspnoea (28.80%), wheezing (24.60%) and sputum (40.50%) occurred more commonly than in other groups. Moreover, these symptoms occurred significantly less frequently in adolescents, who did not use e-cigarettes and traditional cigarettes than in the groups using traditional cigarettes or e-cigarettes only. Dyspnoea and wheezing occurred equally frequently in traditional cigarette smokers and e-cigarette users, whereas sputum was reported more frequently by traditional cigarette smokers (33.70%) and e-cigarette users (26.60%).
The adolescents in the dual user group indicated trouble catching breath during the day and difficulty breathing at night more commonly than adolescents in other groups. Non-smoking school students reported trouble catching breath during the day significantly less frequently than traditional cigarette smokers (p < 0.001). Chest discomfort, including pain and pressure, was also reported more often by adolescents, who used e-cigarettes and traditional cigarettes concurrently (27.60%) compared to their peers in other groups. Chest pressure was experienced less commonly by non-smoking adolescents (14.40%) than by smokers (18.90%).
The next analysis concerned the incidence of symptoms in adolescents smoking traditional cigarettes and the ones who did not smoke (regardless of whether they used e-cigarettes or not). The results of this analysis were presented in Table 2. Cough during the day, cough at night, dyspnoea, difficulty breathing during the day, difficulty breathing during sleep, wheezing, chest pain, chest pressure and sputum were more frequently reported in the group of children smoking traditional cigarettes and turned out to be statistically significantly more common in children smoking traditional cigarettes (p < 0.001), but the effect size was low.
The following comparative analysis concerned the incidence of symptoms in adolescents using e-cigarettes and the ones who did not use this product (regardless of whether they smoked traditional cigarettes or not). The results, of which nine were statistically significant (p < 0.001), were presented in Table 3 Cough during the day, cough at night, dyspnoea / difficulty breathing, trouble catching breath during the day, difficulty breathing during sleep, wheezing, chest pain, chest pressure and sputum were more frequently reported in the group of adolescents using e-cigarettes. However, the effect size was low.
The severity of specific symptoms depending on the use of e-cigarettes and traditional cigarettes.
In the end, we checked whether the increased frequency of occurrence of certain respiratory symptoms is significantly correlated with e-cigarette and traditional cigarette use. Thus, we performed a series of Kruskal-Wallis tests in the four groups of adolescents. The obtained results were presented in Table 4 and all turned out to be statistically significant. Due to this fact, we also conducted a series of post-hoc analyses with the application of Dunn–Šidák correction.
Higher severity of cough during the day and at night was observed in the group of adolescents using traditional cigarettes and e-cigarettes concurrently compared to the other groups. The smoking adolescents reported more severe cough during the day and at night compared to both non-smokers and adolescents using e-cigarettes only. The adolescents in the dual user group experienced more severe dyspnoea and wheezing compared to the other groups included in the comparison. The symptoms were less severe in non-smokers than in adolescents smoking traditional cigarettes or using e-cigarettes only. Analysing the occurrence of symptoms related to trouble catching breath during the day and at night, it was found that in adolescents using e-cigarettes and smoking traditional cigarettes concurrently, these symptoms were more severe compared to the other groups. Non-smoking adolescents had less breathing difficulties than smokers or e-cigarette users. Chest pain and pressure was found to be more severe in the group of adolescents classified as dual users.
Also in the case of sputum, the adolescents using e-cigarettes and smoking traditional cigarettes reported the most severe symptoms. In addition, more severe discomfort associated with sputum was reported by traditional cigarette smokers than e-cigarette users.
4. Discussion
In the recent years, we have observed an increase in the popularity of e-cigarettes as an alternative to traditional tobacco products, The effect of this trend on public health, especially in the context of health of children and adolescents, has become a subject of an increased interest among scientists and the public. Adolescents constitute a group of special concern when it comes to the use of tobacco products and e-cigarettes because they tend to experiment with various forms of stimulants, including e-cigarettes.
There are studies regarding the effect of smoking traditional cigarettes on respiratory health. Thus, considerable attention is also paid to potential health hazards associated with the use of e-cigarettes by adolescents. There is an increasing number of studies analysing the correlation between e-cigarette use and various respiratory symptoms in children and adolescents.
In various studies, the authors use different variables to compare the group of e-cigarette users with users of other nicotine delivery products, and they also use various classifications and comparisons in terms of frequency or history of use of various tobacco products. This is a common topic in scientific literature because there is no consensus on how to measure the effects of the use of e-cigarettes and tobacco products.
In this work, we have adopted a simple and practical division of adolescents into four study groups according to the use of tobacco products into non-smokers, traditional cigarette smokers, e-cigarette users and dual users. The non-smoker group included adolescents who had never used any tobacco products. The traditional cigarette smoker group included adolescents who regularly smoked conventional cigarettes, while the group of e-cigarette users consisted of adolescents who used e-cigarettes without using traditional cigarettes. The dual user group included adolescents who used both e-cigarettes and traditional cigarettes. By making this division, we could study the differences between these groups regarding the respiratory symptoms more accurately, and evaluate the potential health hazard associated with various forms of tobacco product use by children and adolescents.
Our study stands out of other scientific works due to the special focus on the issue of concurrent use of both traditional cigarettes and e-cigarettes by children and adolescents. Although there is an increasing number of studies concerning the effect of every form of smoking on the respiratory system, not much attention is devoted to concurrent use of both these products in the same age group. We have conducted a detailed analysis of the incidence of respiratory symptoms in the study group, highlighting the need to understand and evaluate the effect of dual use of traditional cigarettes and e-cigarettes on the health of children and adolescents.
In turn, the authors of the PATH study performed an analysis of the effect of e-cigarette use on the respiratory system in relation to the duration of smoking. In stages 3 and 4 of the PATH study, which took place between October 2015 and January 2018, the occurrence of wheezing in the previous year was assessed in adolescents aged 12-17 years who declared smoking e-cigarettes in the previous 7 days, 30 days, and one year and a group of adolescents who claimed that they had never used e-cigarettes. In the study group, 8.1% surveyed adolescents confirmed experiencing wheezing within the previous 12 months. Electronic cigarette use was associated with a relatively high odds of wheezing in the last 12 months in the unadjusted model (OR, 1.74; 95% CI, 1.22-2.48]; it was slightly lower in those who had smoked in the previous 30 days (OR,1.66; 95% CI, 0.86-3.21) and in the previous 7 days (OR1.31;95% CI, 0.63-2.69). In turn, in the adjusted model, the correlation between the use of e-cigarettes and wheezing was significantly lower in adolescents who used ENDC in the previous year (aOR 1.37 95% CI, 0.91-2.05), in the previous 30 days (aOR1.35;95% CI, 0.63-2.88), and in the previous 7 days (aOR, 0.74 95% CI, 0.28-1.97) [15].
In the subsequent study, the researchers divided adolescents into similar groups as in our work. The data come from the 4th and 5th stage of the PATH study [16]. The results were analysed to examine the correlation between tobacco smoking and the use of electronic nicotine delivery systems, including dual users, and the incidence of respiratory diseases. The study demonstrated that concurrent use of traditional and electronic nicotine products was associated with the risk of respiratory diseases in adolescents. Exclusive use of traditional cigarettes (aOR = 2.10, 95% CI = 1.17–3.77), e-cigarettes (aOR = 1.03, 95% CI = 0.49–2.16), and concurrent use of both products (aOR = 2.02, 95% CI = 1.20–3.40) was associated with a greater likelihood of an increased risk of respiratory diseases compared to not using any nicotine delivery products [16].
Our results are in accordance with the results obtained in the 4th and 5th stage of the PATH study; all the analysed respiratory symptoms were most prevalent in the group of adolescents using traditional cigarettes and e-cigarettes concurrently.
In order to evaluate the effect of e-cigarette use on respiratory health using the 2012-2013 Global Tobacco Survey, a cross-sectional study was performed in Hong Kong among 45,128 adolescents aged 12-17 years [17]. The use of e-cigarettes was determined based on a survey conducted among school students, who declared themselves as non-smokers, current, experimental or past e-cigarette users. That study demonstrated a significant correlation between the use of e-cigarettes and increased risk of chronic cough and sputum. Respiratory symptoms were defined as cough or sputum persisting for 3 consecutive months within the previous 12 months. Detailed data analysis demonstrated that 33.9% e-cigarette users reported these symptoms compared to 19.4% of non-users. The probability (OR) of the occurrence of these symptoms in e-cigarette users was 2.13 (95% CI: 1,82–2.48, p < 0.01), and the adjusted OR was 1.28 (95% CI: 1.06–1,56, p < 0.05). The study demonstrated a significant correlation between respiratory symptoms and the use of e-cigarettes compared to people who never used e-cigarettes (OR: 2.09, 95% CI: 1.27–3.44, p < 0.01; adjusted OR: 2.06, 95% CI: 1.24–3.42, p < 0.01), incidental smokers (OR: 1.45, 95% CI: 1.19–1.78; adjusted OR: 1.39, 95% CI: 1.14–1.7, p < 0.01) and former smokers (OR: 1.46, 95% CI: 1.07–2.00 adjusted OR: 1.4; 95% CI: 1.02–1.91, p < 0.05) [17].
In 2014, Southern California Children’s Health Study performed among 11th and 12th grade students demonstrated that the risk of occurrence of chronic cough, sputum or bronchitis increased almost twofold among both former and current e-cigarette users. However, no statistically significant correlation was found between the use of e-cigarettes and the occurrence of wheezing. The study was conducted in schools among 502 school students aged 16-18 years using a questionnaire. The use of e-cigarettes was defined in a similar way as past or current e-cigarette use. Additionally, there was also a control group consisting of students who had never used e-cigarettes. The analysed respiratory symptoms included symptoms associated with chronic bronchitis; the study participants were asked whether they had experienced daily cough, rhinitis or sputum for 3 consecutive months. The symptoms of bronchitis was reported by 17.3% subjects who had never used e-cigarettes, 24.2% former users and 35.5% current users. A correlation was demonstrated between the symptoms of bronchitis and the use of e-cigarettes in the past (odds ratio [OR]: 1.85, 95% confidence interval [CI]: 1.37–2.49) and current users (OR: 2.02, 95% CI: 1.42 –2.88). The risk of occurrence of bronchitis symptoms increased with higher frequency of e-cigarette use (OR: 1.66, 95% CI: 1.02–2.68 for 1–2 days) (OR: 2.52, 95% CI: 1.56–4.08 for 3 days or longer) compared to study participants who had never used e-cigarettes [18].
In contrast to other authors, we distinguished two different types of cough in our survey: daytime cough and nighttime cough. In terms of the occurrence of cough and sputum, the results of our study correspond with the study performed among adolescents in Hong Kong and California. In our study, 24.8% adolescents using e-cigarettes and 39.7% dual users reported cough during the day, while 7.8% and 18.4%, respectively, reported cough at night. Analysing the accumulation of sputum, we demonstrated that the symptom occurs in 26.6% adolescents using e-cigarettes and 40.5% dual users. Adolescents in the dual user group experienced more frequent and more severe cough during the day and sputum accumulation than the other groups.
In 2015–2016, Cherian et al conducted a study to assess the correlation between vaping and the occurrence of respiratory symptoms among adolescents following a significant increase in national rates of ENDS use among youth in the US. Using the data from the PATH study constituting a representative dataset for the US, they observed that adolescents who reported using ENDS in the past 12 months, compared with their peers who did not use ENDS in the past 12 months, had a greater overall risk of wheezing. They also found that the risk of dry cough at night was higher in school students using e-cigarettes within the previous 12 months than in non-smokers. The results partly confirm the hypothesis that the use of ENDS by adolescents is associated with respiratory symptoms including cough and wheezing [19].
Our results are in line with those obtained by Cheriant et al. regarding the occurrence of wheezing. Adolescents who do not use any tobacco products reported wheezing less frequently than the ones smoking only traditional cigarettes or only e-cigarettes. This symptom was reported more frequently and was more severe in adolescents in the dual user group than in the other groups. In contrast to Cherian et al., the difference between the occurrence of cough at night in adolescents using e-cigarettes and the ones not using any tobacco products was not statistically significant.
The authors of the LUIS study, conducted in 2013–2016 in the Swiss canton of Zurich, analysed the occurrence of respiratory symptoms in children and adolescents aged 6–17 years who used various tobacco products, including traditional cigarettes, e-cigarettes and shisha. The participants self-reported the occurrence of such symptoms as cough not associated with common cold, more frequent than in their peers, rhinitis, dry mouth after waking up, dyspnoea, spontaneous wheezing and wheezing after physical effort. The results of the study confirmed that the use of any tobacco products by adolescents was associated with higher incidence of respiratory symptoms. Children and adolescents, who smoked cigarettes, shisha or used e-cigarettes often or only occasionally, reported higher incidence of respiratory symptoms within the previous 12 months than the ones who did not use these products. The smokers also experienced other respiratory symptoms more frequently, including rhinitis not associated with common cold and dry mouth after waking up. Additionally, they reported dyspnoea, unprovoked wheezing and wheezing associated with physical effort. Wheezing and wheezing associated with physical effort occurred more frequently in adolescents who smoked often or occasionally compared to the ones who did not smoke. The results demonstrated that the use of tobacco products may constitute a risk factor for respiratory health in adolescents and highlighted the need to implement preventive measures among the youth [20].
The results of our study turned out to be consistent with the LUIS study with such symptoms as cough, dyspnoea, wheezing and sputum accumulation occurred more frequently in adolescents either smoking traditional cigarettes or using e-cigarettes, as well as dual users, than in their non-smoking peers. Dyspnoea and trouble catching breath were reported more frequently in the dual user group (28.8%), traditional cigarette smokers (22.9%) and e-cigarette users (18.7%). These symptoms were reported by 14.3% non-smoking adolescents.
In the study by King et al., the authors compared the symptoms reported by adolescents using e-cigarettes, traditional cigarettes and other tobacco products (water pipe, small cigars or cigarillos, other types of tobacco) in the previous 30 days compared to adolescents who did not declared the use of tobacco products in the same 30-days’ period. The study identified the probability of increased incidence of symptoms in the case of using more than one tobacco product (polytobacco use) compared to sticking to only one product or not using any form of tobacco at all. The evaluated symptoms included cough, dizziness or lightheadedness, headache or migraine, dry mouth or oral/pharyngeal irritation, dyspnoea and disturbance or loss of taste, More than a half (63.3%) of young people who were using or had ever used e-cigarettes reported the occurrence of one or more symptoms associated with e-cigarette use (in the range from 0 to 5 symptoms). On average, the adolescents reported 1.4 (SE = 0.2) symptoms, including cough (42.3%), dizziness or lightheadedness (31.5%), headache or migraine (25.4%), dry mouth or oral/pharyngeal irritation (14.9%) and dyspnoea (13.7%; see Table 2). Few adolescents reported disturbance or loss of taste (3.5%) or other symptoms (5.7%), including nausea, dry eyes, earache and chest pressure. The study participants who declared e-cigarette use within the previous 30 days reported headache or migraine more frequently than the ones who did not use e-cigarettes in the same 30-days’ period (43.8% vs 14.6%, p = 0.002). Similarly, the participants who declared using e-cigarettes within the previous 30 days more commonly attributed their symptoms to the use of e-cigarettes (86.0% vs 58.6%, p = 0.001) and dyspnoea (33.8% vs 9.5%, p = 0.03). Moreover, the participants who declared the use of another tobacco product within the previous 30 days reported higher incidence of dyspnoea caused by e-cigarette use (31.6% vs 8.2%, p = 0.01). Finally, the participants who declared using more than one product within the previous 30 days reported higher incidence of headache or migraine than the ones who had not used any tobacco products in the same 30-days’ period (39.1% vs 11.7%).
In the case of every group of tobacco product (e-cigarettes, traditional cigarettes, other products) users who had used any product within the previous 30 days reported the occurrence of at least one symptom more frequently than non-smokers, including headache or migraine and dyspnoea. What is more, the participants who had used e-cigarettes within the previous 30 days reported symptoms associated with their use more frequently than those who had not. It is possible that the adolescents using other tobacco products experience more symptoms when using e-cigarettes. It is also possible that the adolescents using other tobacco products may attribute the symptoms associated with the use of other products to e-cigarettes [21].
In our study population of adolescents, the symptom most frequently reported by e-cigarette users was sputum accumulation - 26.6%. The second most prevalent symptom in this group was cough during the day - 24.8%. Our results obtained in the group of dual users, who may be considered as polytobacco users, are in line with the results obtained by King et al.
5. Conclusions
The results of this study confirm the correlation between the occurrence of respiratory symptoms in adolescents who smoke cigarettes, use e-cigarettes and in dual users. The respiratory symptoms occur most frequently and are the most severe in the group of adolescents who use e-cigarettes and traditional cigarettes. By highlighting the aspect of dual use, we have attempted to make an important contribution to the development of knowledge on the effect of smoking on the health status of the young generation and underline the need for intervention aimed at reducing this phenomenon and protecting public health.
Due to the dynamics of the tobacco product market and the evolving forms of tobacco use, it is necessary to continuously monitor and evaluate the effect of e-cigarette use on the health of young people.
References
- WHO, The Global Youth Tobacco Survey in Selected Countries of the Who European Region. Available online: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/global-youth-tobacco-survey (accessed on 07.05.2024).
- D. M. Smith, M. Gawron, L. Balwicki, A. Sobczak, M. Matynia, and M. L. Goniewicz, “Exclusive versus dual use of tobacco and electronic cigarettes among adolescents in Poland, 2010–2016,” Addict. Behav. 2019, vol. 90, no. November 2018, pp. 341–348.
- C. A. Stanton et al., “Initiation of any tobacco and five tobacco products across 3 years among youth, young adults and adults in the USA: Findings from the PATH Study Waves 1-3 (2013-2016),” Tob. Control 2020, vol. 29, pp. S178–S190.
- K. A. Cullen et al., “Vital Signs: Tobacco Product Use Among Middle and High School Students — United States, 2011–2018 Andrea,” MMWR. Morb. Mortal. Wkly. Rep. 2019, vol. 68, no. 39, pp. 839–844.
- P. Booth, I. P. Albery, S. Cox, and D. Frings, “Survey of the effect of viewing an online e-cigarette advertisement on attitudes towards cigarette and e-cigarette use in adults located in the UK and USA: A cross-sectional study,” BMJ Open 2019, vol. 9, no. 6, pp. 1–7.
- D. G. Chapman et al., “The Effect of Flavored E-cigarettes on Murine Allergic Airways Disease,” Sci. Rep. 2019, vol. 9, no. 1, pp. 1–11.
- C. Cherian, E. Buta, P. Simon, R. Gueorguieva, and S. Krishnan-Sarin, “Association of vaping and respiratory health among youth in the population assessment of tobacco and health (Path) study wave 3,” Int. J. Environ. Res. Public Health 2021, vol. 18, no. 15.
- D. L. Overbeek, A. P. Kass, L. E. Chiel, E. W. Boyer, and A. M. H. Casey, “A review of toxic effects of electronic cigarettes/vaping in adolescents and young adults,” Crit. Rev. Toxicol. 2020, vol. 50, no. 6, pp. 531–538.
- B. W. Chaffee et al., “E-cigarette use and adverse respiratory symptoms among adolescents and Young adults in the United States,” Prev. Med. (Baltim). 2021, vol. 153, p. 106766.
- F. Moazed and C. S. Calfee, “The canary in the coal mine is coughing: Electronic cigarettes and respiratory symptoms in adolescents,” Am. J. Respir. Crit. Care Med. 2017, vol. 195, no. 8, pp. 974–976.
- M. P. Wang, S. Y. Ho, L. T. Leung, and T. H. Lam, “Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong,” JAMA Pediatr. 2016, vol. 170, no. 1, pp. 89–91.
- K. Choi and D. Bernat, “E-Cigarette Use Among Florida Youth With and Without Asthma,” Am. J. Prev. Med. 2016, vol. 51, no. 4, pp. 446–453.
- R. J. Schweitzer, T. A. Wills, E. Tam, I. Pagano, K. Choi, and H. Disparities, “E-cigarette use and asthma in a multiethnic sample of adolescents,” Prev Med. 2017, pp. 226–231.
- . H. Cho and S. Y. Paik, “Association between electronic cigarette use and asthma among high school students in South Korea,” PLoS One 2016, vol. 11, no. 3, pp. 1–13.
- P. Tackett et al., “Evaluation of Respiratory Symptoms Among Youth e-Cigarette Users,” JAMA Netw. Open 2020, vol. 3, no. 10, p. e2020671.
- D. N. Bhatta and R. Adhikari, “Incident respiratory disease among youths using combustible tobacco, electronic nicotine products, or both: a longitudinal analysis,” World J. Pediatr. 2022, vol. 18, no. 11, pp. 786–790.
- M. P. Wang, S. Y. Ho, L. T. Leung, and T. H. Lam, “Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong,” JAMA Pediatr. 2016, vol. 170, no. 1, pp. 89–91.
- R. McConnell et al., “Electronic cigarette use and respiratory symptoms in adolescents,” Am. J. Respir. Crit. Care Med. 2017, vol. 195, no. 8, pp. 1043–1049.
- Cherian, E. Buta, P. Simon, R. Gueorguieva, and S. Krishnan-Sarin, “Association of vaping and respiratory health among youth in the population assessment of tobacco and health (Path) study wave 3,” Int. J. Environ. Res. Public Health 2021, vol. 18, no. 15.
- Mozun et al., “Cigarette, shisha, and electronic smoking and respiratory symptoms in Swiss children: The LUIS study,” Pediatr. Pulmonol. 2020, vol. 55, no. 10, pp. 2806–2815.
- J. L. King, B. A. Reboussin, J. W. Merten, K. D. Wiseman, K. G. Wagoner, and E. L. Sutfin, “Negative health symptoms reported by youth e-cigarette users: Results from a national survey of US youth,” Addict. Behav. 2020, vol. 104, no. January, pp. 6–10.
Table 1.
The occurrence of specific symptoms depending on the use of e-cigarettes and traditional cigarettes.
Table 1.
The occurrence of specific symptoms depending on the use of e-cigarettes and traditional cigarettes.
| do not use tobacco products (n = 8234) |
smoke traditional cigarettes (n = 608) |
use e-cigarettes (n = 879) |
use traditional cigarettes and e-cigarettes (n = 667) |
||
| Cough during the day | 1835 | 200 | 218 | 265 | χ2(3) = 129.23 p < 0.001 V = 0.11 |
| 22.30% | 32.90% | 24.80% | 39.70% | ||
| Cough at night | 638 | 83 | 69 | 123 | χ2(3) = 107.53 p < 0.001 V = 0.10 |
| 7.70% | 13.70% | 7.80% | 18.40% | ||
| Shortness of breath or breathing difficulties | 1177 | 139 | 164 | 192 | χ2(3) = 124.20 p < 0.001 V = 0.11 |
| 14.30% | 22.90% | 18.70% | 28.80% | ||
| Trouble catching breath during the day | 982 | 101 | 120 | 172 | χ2(3) = 109.96 p < 0.001 V = 0.10 |
| 11.90% | 16.60% | 13.70% | 25.80% | ||
| Breathing difficulties during sleep | 496 | 37 | 57 | 97 | χ2(3) = 72.84 p < 0.001 V = 0.08 |
| 6.00% | 6.10% | 6.50% | 14.50% | ||
| Wheezing sounds in the chest | 428 | 89 | 102 | 164 | χ2(3) = 407,73 p < 0.001 V = 0.20 |
| 5.20% | 14.60% | 11.60% | 24.60% | ||
| Chest pain | 1273 | 119 | 152 | 192 | χ2(3) = 82.91 p < 0.001 V = 0.09 |
| 15.50% | 19.60% | 17.30% | 28.80% | ||
| Tightness in the chest | 1182 | 115 | 154 | 184 | χ2(3) = 89.21 p < 0.001 V = 0.09 |
| 14.40% | 18.90% | 17.50% | 27.60% | ||
| Bronchial secretions requiring coughing out | 1534 | 205 | 234 | 270 | χ2(3) = 249.15 p < 0.001 V = 0.16 |
| 18.60% | 33.70% | 26.60% | 40.50% |
Table 2.
The occurrence of specific symptoms depending on the use of traditional cigarettes.
| do not smoke traditional cigarettes (n = 9113) |
smoke traditional cigarettes (n = 1275) |
χ2 | Odds ratio (95% CI) |
|
| Cough during the day | 2053 | 465 | χ2(1) = 118.40 p < 0.001 V = 0.11 |
1.97% |
| 22.50% | 36.50% | (1,74 – 2,24) | ||
| Cough at night | 707 | 206 | χ2(1) = 98.42 p < 0.001 V = 0.10 |
2.29% |
| 7.80% | 16.20% | (1.94 - 2.71) | ||
| Shortness of breath or breathing difficulties | 1341 | 331 | χ2(1) = 104.74 p < 0.001 V = 0.10 |
2.03% |
| 14.70% | 26.00% | (1.77 – 2.33) | ||
| Trouble catching breath during the day | 1102 | 273 | χ2(1) = 84.58 p < 0.001 V = 0.09 |
1.98% |
| 12.10% | 21.40% | (1.71 – 2.30) | ||
| Breathing difficulties during sleep | 553 | 134 | χ2(1) = 35.73 p < 0.001 V = 0.06 |
1.82% |
| 6.10% | 10.50% | (1.49 – 2.22) | ||
| Wheezing sounds in the chest | 530 | 253 | χ2(1) = 315.78 p < 0.001 V = 0.17 |
4.01% |
| 5.80% | 19.80% | (3.41 – 4.72) | ||
| Chest pain | 1425 | 311 | χ2(1) = 61.60 p < 0.001 V = 0.08 |
1.74% |
| 15.60% | 24.40% | (1.51 – 2.00) | ||
| Tightness in the chest | 1336 | 299 | χ2(1) = 65.17 p < 0.001 V = 0.08 |
1.78% |
| 14.70% | 23.50% | (1.55 – 2.06) | ||
| Bronchial secretions requiring coughing out | 1768 | 475 | χ2(1) = 210.60 p < 0.001 V = 0.14 |
2.47% |
| 19.40% | 37.30% | (2.18 – 2.80) |
Table 3.
The occurrence of specific symptoms depending on the use of e-cigarettes.
| Do not use e-cigarettes (n = 8842) |
Use e-cigarettes (n = 1546) |
Odds ratio (95% CI) |
||
| Cough during the day | 2035 | 483 | χ2(1) = 48.50 p < 0.001 V = 0.07 |
1.52% |
| 23.00% | 31.20% | (1.35 – 1.71) | ||
| Cough at night | 721 | 192 | χ2(1) = 29.86 p < 0.001 V = 0.05 |
1.60% |
| 8.20% | 12.40% | (1.35 – 1.89) | ||
| Shortness of breath or breathing difficulties | 1316 | 356 | χ2(1) = 64.62 p < 0.001 V = 0.08 |
1.71% |
| 14.90% | 23.00% | (1.50 – 1.95) | ||
| Trouble catching breath during the day | 1083 | 292 | χ2(1) = 50.51 p < 0.001 V = 0.07 |
1.67% |
| 12.20% | 18.90% | (1.45 – 1.92) | ||
| Breathing difficulties during sleep | 533 | 154 | χ2(1) = 32.96 p < 0.001 V = 0.06 |
1.73% |
| 6.00% | 10.00% | (1.43 – 2.08) | ||
| Wheezing sounds in the chest | 517 | 266 | χ2(1) = 243.60 p < 0.001 V = 0.15 |
3.35% |
| 5.80% | 17.20% | (2.85 – 3.92) | ||
| Chest pain | 1392 | 344 | χ2(1) = 40.04 p < 0.001 V = 0.06 |
1.53% |
| 15.70% | 22.30% | (1.34 – 1.75) | ||
| Tightness in the chest | 1297 | 338 | χ2(1) = 51.36 p < 0.001 V = 0.07 |
1.63% |
| 14.70% | 21.90% | (1.42 – 1.86) | ||
| Bronchial secretions requiring coughing out | 1739 | 504 | χ2(1) = 130.00 p < 0.001 V = 0.11 |
1.98% |
| 19.70% | 32.60% | (1.76 – 2.22) |
Table 4.
The severity of specific symptoms depending on the use of e-cigarettes and traditional cigarettes.
Table 4.
The severity of specific symptoms depending on the use of e-cigarettes and traditional cigarettes.
| c | do not use tobacco products (n = 8234) |
smoke traditional cigarettes (n = 608) |
use e-cigarettes (n = 879) |
use traditional cigarettes and e-cigarettes (n = 667) |
||||||
| M | SD | M | SD | M | SD | M | SD | F | p | |
| Cough during the day | 0.45% | 1.12% | 0.75% | 1.42% | 0.60% | 1.45% | 1.23% | 2.24% | 160.14% | 0.001% |
| Cough at night | 0.16% | 0.77% | 0.27% | 0.90% | 0.22% | 1.01% | 0.69% | 1.97% | 115.44% | 0.001% |
| Shortness of breath or breathing difficulties | 0.36% | 1.19% | 0.52% | 1.28% | 0.50% | 1.41% | 1.07% | 2.33% | 134.94% | 0.001% |
| Trouble catching breath during the day | 0.28% | 1.03% | 0.43% | 1.24% | 0.38% | 1.27% | 0.96% | 2.27% | 121.35% | 0.001% |
| Breathing difficulties during sleep | 0.14% | 0.79% | 0.13% | 0.68% | 0.21% | 1.05% | 0.59% | 1.91% | 77.29% | 0.001% |
| Wheezing sounds in the chest | 0.13% | 0.74% | 0.40% | 1.22% | 0.30% | 1.10% | 0.83% | 2.09% | 416,81 | 0.001% |
| Chest pain | 0.38% | 1.21% | 0.57% | 1.52% | 0.43% | 1.35% | 1.02% | 2.27% | 93.87% | 0.001% |
| Tightness in the chest | 0.35% | 1.16% | 0.53% | 1.50% | 0.45% | 1.38% | 1.00% | 2.32% | 99.03% | 0.001% |
| Bronchial secretions requiring coughing out | 0.46% | 1.36% | 1.10% | 2.13% | 0.76% | 1.74% | 1.46% | 2.56% | 287.12% | 0.001% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
MDPI Initiatives
Important Links
© 2024 MDPI (Basel, Switzerland) unless otherwise stated